OxPhosgastric cancerMC38 murine colorectal cancerNDUFS4NDUFA7
…the metabolic and functional suppression observed with existing OxPhos inhibitors. In vivo, NDUFA7 knockdown MC38 tumors show signific…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 342 of 2459topotecanSmall cell lung cancerM6620SCLCataxia telangiectasiachemotherapyVX970
…s ATR inhibitor, M6620 (VX970, berzosertib), and TOP1 inhibitor topotecan, in patients with relapsed SCLCs, validated the induction of MH…
CRCColorectal cancer
…otherapy-refractory orthotopic primary and metastatic mouse MSS CRC tumor lesions. In both human and mouse, we saw a striking upreg…
pembrolizumabpembrolizumab-basedGastric cancerPD-1 inhibitorFudan UniversityCCR8 antagonistGCZhongshan Hospital
…nical outcomes but superior immunotherapeutic responsiveness to pembrolizumab in GC. Transcriptomic and phenotypic analyses revealed that tum…
vascular leak syndromecytokine release syndromeDaiad-2/15Daiad TM-2/15Neo-2/15IL-2IL-15
…e to systemic toxicity, including cytokine release syndrome and vascular leak syndrome. Versions of IL-2 with reduced potency have been studied but re…
melanomaNational Institutes of HealthCancerneuroblastomahead and neck cancergliomasarcomaRachel Lynn Henley FoundationHopes and Smiles For Children Foundationrefractory solid tumors+1 more
…ult and pediatric solid tumors including neuroblastoma, glioma, melanoma and sarcoma.Acknowledgements This work was supported by researc…
ovarian cancerPARPiolaparib
…ors (PARPi) have significantly improved outcomes for women with ovarian cancer. This is attributed to primary effects on DNA repair pathways t…
VAX014San Diego State UniversityVAX014-treatedgastric cancerbladder cancer
…, Nelson K, Proclivo VH, McGuire KL, Giacalone MJ. Intravesical VAX014 synergizes with PD-L1 blockade to enhance local and systemic co…
solid tumorsNorthwestern UniversityB10G5B10G5-treatedprostate tumorsB10G5-mediatedsMIC
… major barrier to realizing their full therapeutic potential in solid tumors. Increasing evidence suggests that maintenance of a stem-like N…
solid tumorsTJ-CP3BBiTCE-C1
… represent limited intra-tumoral T cell infiltration typical of solid tumors, TJ-CP3B demonstrated enhanced and sustained tumor-specific cyt…
lithium
… 10th Revision (ICD-10) healthcare database diagnosis codes for lithium toxicity at hospital admission in Ontario, Canada.Design Popula…